IDEAS home Printed from https://ideas.repec.org/r/oup/renvpo/v1y2007i2p283-299.html
   My bibliography  Save this item

Policy Monitor How US Government Agencies Value Mortality Risk Reductions

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Christian Gollier, 2020. "Cost–benefit analysis of age‐specific deconfinement strategies," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 22(6), pages 1746-1771, December.
  2. James K. Hammitt, 2020. "Valuing mortality risk in the time of COVID-19," Journal of Risk and Uncertainty, Springer, vol. 61(2), pages 129-154, October.
  3. Svetlana Pashchenko & Ponpoje Porapakkarm, 2022. "Value of life and annuity demand," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 89(2), pages 371-396, June.
  4. Henrik Andersson & Nicolas Treich, 2011. "The Value of a Statistical Life," Chapters, in: André de Palma & Robin Lindsey & Emile Quinet & Roger Vickerman (ed.), A Handbook of Transport Economics, chapter 17, Edward Elgar Publishing.
  5. Adler, Matthew & Hammitt, James & Treich, Nicolas, 2012. "The Social Value of Mortality Risk Reduction: VSL vs. the Social Welfare Function Approach," LERNA Working Papers 12.08.365, LERNA, University of Toulouse.
  6. Hammitt, James K., 2020. "Accounting for the distribution of benefits & costs in benefit-cost analysis," TSE Working Papers 20-1116, Toulouse School of Economics (TSE).
  7. Joseph E. Aldy, 2019. "Birds of a feather: Estimating the value of statistical life from dual-earner families," Journal of Risk and Uncertainty, Springer, vol. 58(2), pages 187-205, June.
  8. Svetlana Pashchenko & Ponpoje (Poe) Porapakkarm & Mariacristina De Nardi, 2017. "The Lifetime Costs of Bad Health," 2017 Meeting Papers 533, Society for Economic Dynamics.
  9. Blake C Alkire & Jeffrey R Vincent & Christy Turlington Burns & Ian S Metzler & Paul E Farmer & John G Meara, 2012. "Obstructed Labor and Caesarean Delivery: The Cost and Benefit of Surgical Intervention," PLOS ONE, Public Library of Science, vol. 7(4), pages 1-10, April.
  10. Lakdawalla, Darius N. & Seabury, Seth A., 2012. "The welfare effects of medical malpractice liability," International Review of Law and Economics, Elsevier, vol. 32(4), pages 356-369.
  11. Christian Gollier, 2020. "If the Objective is Herd Immunity, on Whom Should it be Built?," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 76(4), pages 671-683, August.
  12. Jonathan M. Lee & Laura O. Taylor, 2019. "Randomized Safety Inspections and Risk Exposure on the Job: Quasi-experimental Estimates of the Value of a Statistical Life," American Economic Journal: Economic Policy, American Economic Association, vol. 11(4), pages 350-374, November.
  13. Adler, Matthew D. & Ferranna, Maddalena & Hammitt, James K. & Treich, Nicolas, 2021. "Fair innings? The utilitarian and prioritarian value of risk reduction over a whole lifetime," Journal of Health Economics, Elsevier, vol. 75(C).
  14. Evans, Mary F. & Schaur, Georg, 2010. "A quantile estimation approach to identify income and age variation in the value of a statistical life," Journal of Environmental Economics and Management, Elsevier, vol. 59(3), pages 260-270, May.
  15. Yasushi Iwamoto, 2021. "Welfare economics of managing an epidemic: an exposition," The Japanese Economic Review, Springer, vol. 72(4), pages 537-579, October.
  16. Hammitt, James & Haninger, Kevin, 2011. "Valuing Morbidity Risk: Willingness to Pay per Quality-Adjusted Life Year," LERNA Working Papers 11.09.343, LERNA, University of Toulouse.
  17. Hammitt, James K. & Treich, Nicolas, 2021. "Fatality Risk Regulation," TSE Working Papers 21-1177, Toulouse School of Economics (TSE).
  18. Louise Russell, 2014. "The Science of Making Better Decisions about Health: Cost-Effectiveness and Cost-Benefit Analysis," Departmental Working Papers 201406, Rutgers University, Department of Economics.
  19. Kevin Haninger & James K. Hammitt, 2011. "Diminishing Willingness to Pay per Quality‐Adjusted Life Year: Valuing Acute Foodborne Illness," Risk Analysis, John Wiley & Sons, vol. 31(9), pages 1363-1380, September.
  20. Doucouliagos, Chris & Stanley, T.D. & Giles, Margaret, 2012. "Are estimates of the value of a statistical life exaggerated?," Journal of Health Economics, Elsevier, vol. 31(1), pages 197-206.
  21. Anna Alberini & Stefania Tonin & Margherita Turvani, 2009. "The Value of Reducing Cancer Risks at Contaminated Sites: Are More Heavily Exposed People Willing to Pay More?," Working Papers 2009.60, Fondazione Eni Enrico Mattei.
  22. Lisa A. Robinson, 2009. "Valuing lives, valuing risks, and respecting preferences in regulatory analysis," Regulation & Governance, John Wiley & Sons, vol. 3(3), pages 298-305, September.
  23. Benjamin D. Sommers, 2017. "State Medicaid Expansions and Mortality, Revisited: A Cost-Benefit Analysis," American Journal of Health Economics, MIT Press, vol. 3(3), pages 392-421, Summer.
  24. Adler, Matthew D. & Hammitt, James K. & Treich, Nicolas, 2014. "The social value of mortality risk reduction: VSL versus the social welfare function approach," Journal of Health Economics, Elsevier, vol. 35(C), pages 82-93.
  25. Anthony M. Barrett, 2010. "Cost Effectiveness of On-Site Chlorine Generation for Chlorine Truck Attack Prevention," Decision Analysis, INFORMS, vol. 7(4), pages 366-377, December.
  26. Dockins, Chris & Maguire, Kelly & Newbold, Steve & Simon, Nathalie & Krupnick, Alan & Taylor, Laura, 2018. "What’s in a Name? A Systematic Search for Alternatives to “Value of Statistical Life”," RFF Working Paper Series 18-14, Resources for the Future.
  27. Kousky, Carolyn & Lingle, Brett & Ritchie, Liesel & Tierney, Kathleen, 2017. "Social Return on Investment Analysis and Its Applicability to Community Preparedness Activities: Calculating Costs and Returns," RFF Working Paper Series 17-12, Resources for the Future.
  28. Joseph H. Cook, 2013. "Principles and standards for benefit–cost analysis of public health preparedness and pandemic mitigation programs," Chapters, in: Scott O. Farrow & Richard Zerbe, Jr. (ed.), Principles and Standards for Benefit–Cost Analysis, chapter 3, pages 110-152, Edward Elgar Publishing.
  29. Milan Ščasný & Anna Alberini, 2012. "Valuation of Mortality Risk Attributable to Climate Change: Investigating the Effect of Survey Administration Modes on a VSL," IJERPH, MDPI, vol. 9(12), pages 1-22, December.
  30. Dan Zhao & Parham Azimi & Brent Stephens, 2015. "Evaluating the Long-Term Health and Economic Impacts of Central Residential Air Filtration for Reducing Premature Mortality Associated with Indoor Fine Particulate Matter (PM 2.5 ) of Outdoor Origin," IJERPH, MDPI, vol. 12(7), pages 1-32, July.
  31. Lisa A. Robinson & James K. Hammitt, 2015. "Research Synthesis and the Value per Statistical Life," Risk Analysis, John Wiley & Sons, vol. 35(6), pages 1086-1100, June.
  32. Benjamin A. Jones, 2017. "The social costs of uranium mining in the US Colorado Plateau cohort, 1960–2005," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 62(4), pages 471-478, May.
  33. Scotton Carol R., 2013. "New risk rates, inter-industry differentials and the magnitude of VSL estimates," Journal of Benefit-Cost Analysis, De Gruyter, vol. 4(1), pages 39-80, March.
  34. Blomquist, Glenn C. & Dickie, Mark & O'Conor, Richard M., 2011. "Willingness to pay for improving fatality risks and asthma symptoms: Values for children and adults of all ages," Resource and Energy Economics, Elsevier, vol. 33(2), pages 410-425, May.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.